Cvs Health (CVS) Change in Accured Expenses (2009 - 2026)

Cvs Health (CVS) has 18 years of Change in Accured Expenses data on file, last reported at -$196.0 million in Q1 2026.

• Quarterly Change in Accured Expenses fell 110.45% year-over-year to -$196.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$59.0 million (up 96.55% YoY) and the FY2025 annual result came in at $2.0 billion, up 156.83% from the prior year.
• Change in Accured Expenses improved to -$196.0 million in Q1 2026, from -$855.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $6.5 billion in Q3 2022 to a low of -$2.4 billion in Q2 2024.
• A 5-year average of $369.3 million and a median of -$196.0 million in 2026 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2024 — Change in Accured Expenses tumbled 632.89% — and 2025, when it soared 3978.26%.
• Tracing CVS's Change in Accured Expenses over 5 years: stood at -$908.0 million in 2022, then soared by 44.16% to -$507.0 million in 2023, then gained by 5.52% to -$479.0 million in 2024, then plunged by 78.5% to -$855.0 million in 2025, then jumped by 77.08% to -$196.0 million in 2026.
• The last three Change in Accured Expenses figures came in at -$196.0 million (Q1 2026), -$855.0 million (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.